Want to see NNOX full AI Analyst Report?
NNOX Stock Chart & Stats
$0.88
-$0.01(-1.14%)
At close: 4:00 PM EDT
$0.88
-$0.01(-1.14%)
Day’s Range― - ―
52-Week Range$0.71 - $4.71
Previous Close$0.89
Volume1.06M
Average Volume (3M)1.19M
Market Cap
$65.21M
Enterprise Value$121.82
Total Cash (Recent Filing)$43.85M
Total Debt (Recent Filing)$7.64M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
Sep 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.14
Shares Outstanding78,588,640
10 Day Avg. Volume1,407,980
30 Day Avg. Volume1,194,671
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.30
Price to Sales (P/S)13.93
P/FCF Ratio-4.03
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$3.00Price Target Upside240.91% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-0.62
Revenue Forecast (FY)$25.89M
Bulls Say, Bears Say
Bulls Say
Multi-stream Revenue GrowthGrowth across teleradiology, AI and software indicates expanding use of the company’s broader imaging ecosystem rather than reliance on one product. If these services continue scaling, the mix could support recurring workflow revenue and improve operating leverage over the next several quarters.
Commercial Deployment TractionAn operational reference site and multiple distributor agreements provide evidence that Nano-X is progressing from technology development toward clinical deployment. These relationships can expand market access and create a pathway for equipment, software and service revenue as installations become active.
Low Balance-sheet LeverageVery low leverage limits fixed financial obligations relative to the company’s equity base and avoids the balance-sheet pressure associated with substantial debt. This provides more flexibility to fund commercialization and restructuring, although operating losses still require close liquidity management.
Bears Say
Persistent Unprofitable OperationsNegative gross profit means the business is not yet covering direct costs, while the large net loss shows that scale has not translated into a sustainable earnings model. Until margins turn positive, growth may require continued external funding and may not create durable shareholder value.
Cash Burn And Going-concern RiskContinued quarterly cash consumption reduces the time available to reach cash breakeven and makes the commercialization plan dependent on successful execution or additional financing. The explicit going-concern warning signals that liquidity remains a fundamental constraint over the next several quarters.
Uncertain Revenue ConversionWithdrawing guidance and citing delays from signed agreements to installation, activation and utilization weakens confidence in the timing of commercial scale-up. Potential system sales may therefore convert to recognized revenue slowly, complicating planning and prolonging the path to profitability.
Nano-X Imaging News
NNOX FAQ
What was Nano-X Imaging’s price range in the past 12 months?
Nano-X Imaging lowest stock price was $0.71 and its highest was $4.71 in the past 12 months.
What is Nano-X Imaging’s market cap?
Nano-X Imaging’s market cap is $65.21M.
When is Nano-X Imaging’s upcoming earnings report date?
Nano-X Imaging’s upcoming earnings report date is Sep 09, 2026 which is in 2 days.
How were Nano-X Imaging’s earnings last quarter?
Nano-X Imaging released its earnings results on Jun 25, 2026. The company reported -$0.2 earnings per share for the quarter, missing the consensus estimate of -$0.173 by -$0.027.
Is Nano-X Imaging overvalued?
According to Wall Street analysts Nano-X Imaging’s price is currently Undervalued.
Does Nano-X Imaging pay dividends?
Nano-X Imaging does not currently pay dividends.
What is Nano-X Imaging’s EPS estimate?
Nano-X Imaging’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nano-X Imaging have?
Nano-X Imaging has 78,588,640 shares outstanding.
What happened to Nano-X Imaging’s price movement after its last earnings report?
Nano-X Imaging reported an EPS of -$0.2 in its last earnings report, missing expectations of -$0.173. Following the earnings report the stock price went down -44.013%.
Which hedge fund is a major shareholder of Nano-X Imaging?
Currently, no hedge funds are holding shares in NNOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nano-X Imaging Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.00 (240.91% Upside)
$3.00 (240.91% Upside)
Blogger Sentiment
Bullish
NNOX Sentiment 67%
Sector Average 60%
Sector Average 60%
Hedge Fund Trend
Increased
By 73.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $123.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 5.9%
Last 30 Days ▼ 5.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.71%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-25.91%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nano-X Imaging
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
NNOX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mix of operational progress and commercial momentum — including deployments at RadNet, large partner agreements (~360 potential systems), accelerating teleradiology and AI revenues, and cross-division integrations — but these positives are offset by material near-term financial challenges: cash decline, substantial doubt about going concern, continued quarterly cash burn, increased operating losses, withdrawal of 2026 revenue guidance, and timing delays converting agreements into recognized revenue. The tone is cautiously constructive on execution and long-term opportunity but guarded on short-term financial health.View all NNOX earnings summariesNNOX Stock 12 Month Forecast
Average Price Target
$3.00
▲(240.91% Upside)
Technical Analysis
Ownership Overview
0.33% Insiders
2.18% Mutual Funds
1.68% Other Institutional Investors
95.19% Public Companies and
Individual Investors